Nebula Research & Development LLC

SEC CIK: 0001792635
Latest filing: May 15, 2026

SEC filings (opens in a new tab)

TBPH holding history

Theravance Biopharma, Inc. in every 13F filed by Nebula Research & Development LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TBPH overview All 13F holders of TBPH Full Q1 2026 holdings

Shares (Q3 2024): 0; Sold out in Q3 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2023

Holdings of TBPH by Nebula Research & Development LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2024	0	$0	0.0%	−18,154−100.0%	Sold out	Holders
Q2 2024	18,154	$153.9K	<0.1%	+18,154	New	Holders
Q3 2023	0	$0	0.0%	−31,472−100.0%	Sold out	Holders
Q2 2023	31,472	$325.7K	0.2%	+31,472	New	Holders